/ mortonrj's Library/ Notes/ Softgel Capsules Market- By Product Gelatin Softgel Capsule And Non-Gelatin Softgel Capsule
Softgel Capsules Market- By Product Gelatin Softgel Capsule And Non-Gelatin Softgel Capsule
from web site
Description
The global Softgel Capsules Market accrued earnings worth approximately 6.75 (USD Billion) in 2020 and is predicted to gain revenue of about 12.89 (USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028. The report offers assessment and analysis of the Softgel Capsules Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Softgel Capsules Market: Overview
Softgel capsule is a solid drug capsule that surrounds liquid center. Additionally, these products are oral dosages same as capsules and are combination of sorbitol, water, gelatin, and opacifier. The product can be included either in outer gelatin capsule shell or inner softgel capsule fill. Furthermore, surge in occurrence of chronic disorders are expected to create massive demand for softgel capsules in upcoming years. Moreover, these products have plethora of applications in healthcare and pharmaceutical sectors. They are also utilized as medical supplement in heart disorders and antacids.
Softgel Capsules Market: Growth Trends
Softgel capsule is utilized for preventing vitamin deficiency arising due to poor diet and certain kinds of illness. In addition to this, it is easily soluble and can help in delivering ultra-low doses of low melting compound. Moreover, it generates less dust during production, thereby ensuring safety of workers. Apart from this, the drug suspensions with unpleasant taste or odor can be ingested easily in the softgel capsule as the latter provides convenient ingestion. All these aforementioned are anticipated to boost growth of softgel capsules market.
Furthermore, softgel capsules enhance melatonin bioavailability in human beings. Moreover, beneficial features of the product include solubility and tiny particle size. These products possess high dosage accuracy as well as uniformity stability. It can improve bioavailability of poorly soluble medicines. Rise in consumer preference for the product due to its self-lubricating feature as well as its availability in myriad sizes, forms like chewable & meltable forms, and colors will aid growth of softgel capsules market. Nonetheless, high product manufacturing costs and its susceptibility of getting affected in humid or moist environment as well as extreme temperatures can pose threat to growth of industry in coming years.
Regional Landscape
Europe To Lead Growth Of Softgel Capsules Market Over 2021-2028
Expansion of softgel capsules market in Europe over next seven years can be credited to large-scale funding of research activities pertaining to manufacture of softgel capsules in different European countries. Moreover, Gelatin has been recognized as GRAS (Generally Recognized As Safe) food ingredient by FDA and this has proved to be a key growth factor for softgel capsules market in Europe. Increase in product sales and addition of new products to existing product line will chart a profitable growth path for softgel capsules industry in Europe over years to come.
Competitive Landscape
Key players lucratively impacting growth of softgel capsules industry and profiled in study are Catalent, Inc., Capsugel, Elnova Pharma, Hunan ER-KANG Pharmaceutical Co Ltd., Aenova Group GmbH, Guangdong Yichao Biological Co., Ltd., Sirio Pharma Company Ltd, Captek Softgel International Inc, Fuji Capsule Co., Ltd., EuroCaps Ltd., and KD Pharma Group.
The global Softgel Capsules Market is segmented as follows:
By Product
- Non-gelatin Softgel Capsule
- Gelatin Softgel Capsule
By End-User
- Pharmaceutical Companies
- Contract Manufacturing Organizations
By Application
- Anti-inflammatory Drugs
- Antibiotic Drugs
- Health Supplements
- Cardiovascular Drugs
By Region
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
